feed,title,long_url,short_url
SeekingAlpha,Ipsen Onivyde fails to improve overall survival of lung cancer patients in phase 3 trial,https://seekingalpha.com/news/3865492,
SeekingAlpha,Match Group: Growth Dysfunction,https://seekingalpha.com/article/4529007,
